Showing results (91-100 of 114) with videos related to
Sort By:
Pageof 12
Journal of Medicinal Chemistry|January 1, 1991
Novel class of amino acid antagonists at non-N-methyl-D-aspartic acid excitatory amino acid receptors. Synthesis, in vitro and in vivo pharmacology, and neuroprotectionP Krogsgaard-Larsen, J W Ferkany, E O Nielsen, et al.The Journal of Infectious Diseases|December 1, 1994
Development of a live, oral, attenuated vaccine against El Tor choleraD N Taylor, K P Killeen, D C Hack, et al.The Journal of Infectious Diseases|October 1, 1995
Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1J R Kenner, T S Coster, D N Taylor, et al.Lancet (London, England)|April 15, 1995
Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototypeT S Coster, K P Killeen, M K Waldor, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Technology and Dementia PreconferenceNeil W Thomas, Julien Larivière-Chartier, Bahareh Chimehi, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Dementia Care Research and Psychosocial FactorsNeil W Thomas, Julien Larivière-Chartier, Bahareh Chimehi, et al.Glycobiology|June 11, 2004
Production of a complement inhibitor possessing sialyl Lewis X moieties by in vitro glycosylation technologyLawrence J Thomas, Krishnasamy Panneerselvam, David T Beattie, et al.Frontiers in Pharmacology|June 21, 2011
The Pharmacology of TD-8954, a Potent and Selective 5-HT(4) Receptor Agonist with Gastrointestinal Prokinetic PropertiesDavid T Beattie, Scott R Armstrong, Ross G Vickery, et al.British Journal of Pharmacology|October 7, 2004
The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivoD T Beattie, J A M Smith, D Marquess, et al.BMC Genomics|November 30, 2017
Optimizing and evaluating the reconstruction of Metagenome-assembled microbial genomesBhavya Papudeshi, J Matthew Haggerty, Michael Doane, et al.Pageof 12